Macpod O Tablet DT is a combination antibiotic formulation containing Cefpodoxime Proxetil 100 mg and Ofloxacin 100 mg, designed for the treatment of a broad spectrum of bacterial infections. Cefpodoxime Proxetil, a third-generation cephalosporin, exhibits bactericidal activity by inhibiting bacterial cell wall synthesis, effective against both gram-positive and gram-negative organisms. Ofloxacin, a fluoroquinolone antibiotic, acts by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and transcription. The dual mechanism enhances antimicrobial efficacy and helps in managing mixed infections or resistant strains. Macpod O Tablet DT is indicated for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and sexually transmitted infections caused by susceptible bacteria. The tablet is formulated as a dispersible tablet, facilitating ease of administration, especially in patients with swallowing difficulties. Dosage and duration should be determined by a healthcare professional based on infection severity and patient response. Caution is advised in patients with known hypersensitivity to cephalosporins or fluoroquinolones, and use during pregnancy and lactation should be under medical supervision. Adverse effects may include gastrointestinal disturbances, hypersensitivity reactions, and potential tendonitis associated with fluoroquinolones. Proper adherence to prescribed regimens is essential to prevent resistance development.